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 ABSTRACT 
Biological substitutes for autologous bone flaps could be generated by combining flap 
prefabrication and bone tissue engineering concepts. Here, we investigated the pattern of 
neotissue formation within large prefabricated engineered bone flaps in rabbits. 
Bone marrow stromal cells from 12 New Zealand White rabbits were expanded and uniformly 
seeded in porous hydroxyapatite scaffolds (tapered cylinders, 10 to 20 mm diameter, 30 mm 
height) using a perfusion bioreactor. Autologous cell-scaffold constructs were wrapped in a 
panniculus carnosus flap, covered by a semipermeable membrane and ectopically implanted. 
Histological analysis, substantiated by magnetic resonance imaging and micro-computerized 
tomography scans, indicated three distinct zones: an outer one, including bone tissue; a middle 
zone, formed by fibrous connective tissue; and a central zone, essentially necrotic. The depths 
of connective tissue and of bone ingrowth were consistent at different construct diameters and 
significantly increased from respectively 3.1 ± 0.7 mm and 1.0 ± 0.4 mm at 8 weeks to 3.7 ± 0.6 
mm and 1.4 ± 0.6 mm at 12 weeks. Bone formation was found at a maximum depth of 1.8 mm 
after 12 weeks. 
Our findings indicate the feasibility of ectopic prefabrication of large cell-based engineered 
bone flaps and prompt for the implementation of strategies to improve construct vascularization, 
in order to possibly accelerate bone formation towards the core of the grafts. 
 
Key words: Bone tissue engineering; Mesenchymal stem cells; Vascularization; Bone graft; 
Bioreactor; Flap prefabrication 
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 INTRODUCTION 
Vascularization plays a crucial supportive role during bone growth and fracture healing [1]. 
Indeed, formation and repair of bone can be prevented by angiogenesis inhibitors [2,3], as well 
as stimulated by introducing vascular carriers [4]. Therefore, the first choice for surgical 
reconstruction of large bone defects (e.g., segmental defects wider than 6-8 cm [5] or large bone 
losses due to trauma, tumor, and infection [6-8]) consists of autologous bone flaps, namely bone 
grafts with an internal vascular network supplied by large caliber vessels [5]. Using bone flaps, 
the healing process between the graft and host bone is reported to proceed not by creeping 
substitution, as in non-vascularized bone grafts, but similarly to fracture healing [9,10], with 
union times as short as 3-5 months [11].  
However, bone flaps often do not match the mechanical strength required at the bone defect, 
and thus may result in complications such as stress fractures in up to 25% of reconstructions, 
prolonging immobilization or leading to pseudarthrosis [10,12]. Additional limits of autologous 
bone flaps include significant donor site morbidity [13-15], as well as complicated and time 
consuming shaping frequently required intraoperatively, due to the limited anatomically 
available sizes and shapes. 
In order to overcome these limitations and to generate osteogenic grafts of predefined shapes, 
dimensions and mechanical properties, bone tissue engineering using various types of 
osteoprogenitor/stem cells in combination with appropriate carriers has been developed. Several 
studies have established that bone marrow stromal cells (BMSC), expanded in culture and 
loaded into porous ceramic scaffolds, are able to form bone tissue, both ectopically and 
orthotopically (see [16] for a recent review). Despite the report of few clinical cases [17], 
however, no convincing successes have been achieved in humans, most likely because of lack 
of sufficient vascular supply, resulting in immediate cell death after implantation [16,18]. 
Indeed in small constructs, survival of the cells is supported by a short distance from the 
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 surrounding vasculature, while in constructs of clinically relevant size (i.e., a few cubic 
centimeters), the acceptable distance for diffusion of oxygen and nutrients is exceeded.  
In order to solve the size limitations in bone tissue engineering, one possible option is to 
combine it with the concept of flap prefabrication, namely a two-stage surgical procedure 
whereby a new blood supply is transferred into a volume of tissue by the introduction of a 
vascular carrier [19-21]. Bone flap prefabrication is thus aimed at ectopically producing living 
bone tissue in predefined shapes and dimensions, which can then be transferred to a distant site 
with its blood supply [22]. Engineered bone flap prefabrication using a cell-based approach has 
been performed in a few animal models, using constructs of different sizes [23-25]. However, 
the limiting dimension in these models never exceeded 6 mm, and thus would not be 
representative of a graft in a clinically relevant size. Moreover, the depths of vascularization and 
of bone tissue formation have not been assessed in any of these models, and therefore no 
indication on size limits in the prefabrication of engineered bone flaps is available.  
In the present study, we first aimed at establishing a new model of ectopic prefabrication of 
autologous cell-based, large bone flaps in rabbits using porous ceramic scaffolds loaded with 
BMSC and wrapped by a panniculus carnosus flap as an external vascular carrier. We then used 
the model to investigate the spatial pattern and temporal progression of bone formation within 
the scaffolds. In order to exclude the possibility that such pattern was influenced by initially 
non-uniform cell distributions, we adapted and used a previously described direct perfusion 
bioreactor system for spatially homogenous cell seeding [26]. 
 
MATERIALS AND METHODS 
Bone marrow harvest 
The study was approved by the Animal Ethics Committee of the Swiss Federal Veterinary 
Office (http://bvet.admin.ch) and was conducted in accordance with the guidelines for the care 
and maintenance of animals at the University Hospital Basel. Bone marrow was harvested from 
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 12 young adult New Zealand White (NZW) rabbits (Charles River Laboratories, Kisslegg, 
Germany) with an average body weight of 3.2 ± 0.4 kg. Animals were sedated by subcutaneous 
administration of 25 mg per kg of body weight ketamine hydrochloride (Ketaminol 5%® ad us. 
vet., Veterinaria AG, Zürich, Switzerland) and 2.5 mg per kg of body weight xylazine 
(Narcoxyl 2%® ad us. vet., Veterinaria AG, Zürich, Switzerland) before transfer to the operating 
room, where inhalation anesthesia was initiated with isoflurane (Forene®, Abbott AG, Baar, 
Switzerland). Transcutaneous arterial oxygen saturation and heart rate were monitored with a 
pulse oximeter (NPB-290, Nellcor Puritan Bennett, Pleasanton, CA, USA) fixed to a front limb. 
Before surgery, single shot antibiotic prophylaxis with 15 mg per kg of body weight sulfadoxin-
trimethoprim (Borgal® 24% ad us. vet., Veterinaria AG, Zürich, Switzerland) and 0.05 mg per 
kg of body weight buprenorphine (Temgesic®, Essex Chemie AG, Luzern, Switzerland) for 
pain relief were administered subcutaneously. 
After the area over the iliac crests was shaved and prepped with povidone iodine solution 
(Betaseptic®, Mundipharma Medical Company, Basel, Switzerland), bone marrow was 
harvested by repeated puncture of both iliac bones (2-3 per side) using 20 gauge needles and 20 
ml syringes filled with 1 ml of heparin sodium solution (Heparin-Na® 5'000 IU/ml, B. Braun 
Medical AG, Emmenbrücke, Switzerland), yielding average aspirate volumes of 17.3 ± 5.2 ml 
(range: 11.5 - 27 ml) per animal. Fresh aspirates were diluted with a double volume of 
phosphate buffered saline (PBS, Gibco, Invitrogen Corporation, Basel, Switzerland), and 
centrifuged, resulting in the elimination of supernatant fat, blood clots, and small tissue 
particles. Nucleated cells were then stained with crystal violet 2.3% (Sigma-Aldrich, Fluka 
Chemie AG, Buchs, Switzerland), counted and cultured as described below. 
 
BMSC expansion 
The complete medium consisted of α-modified Eagle’s medium (α-MEM with 4.5 mg/ml D-
glucose and 0.1 mM non-essential amino acids, Gibco, Invitrogen Corporation, Basel, 
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 Switzerland) containing 10% foetal bovine serum (FBS), 1% penicillin-streptomycin-glutamate 
(PSG; 10’000 U/ml penicillin, 10’000 µg/ml streptomycin, and 200 mM glutamine), 1% 
HEPES buffer (1 M, Gibco, Invitrogen Corporation, Basel, Switzerland), and 1% sodium 
pyruvate (100 mM, Gibco, Invitrogen Corporation, Basel, Switzerland).  
Nucleated cells from fresh aspirates were plated at a density of 1 x 105 per cm2 in complete 
medium, further supplemented with 5 ng/ml FGF-2 (R&D Systems, Wiesbaden, Germany) and 
10 nM dexamethasone (Sigma-Aldrich, Fluka Chemie AG, Buchs, Switzerland) to increase 
BMSC proliferation and osteogenic commitment [27]. All cell cultures were incubated in 
humidified atmosphere at 37ºC / 5% CO2. Medium was first changed after 5 days, non-adherent 
cells were removed and fresh medium was added, with medium changes twice a week. When 
reaching subconfluency, adherent cells were detached from the flasks using 0.3% collagenase 
(Worthington Biochemical Corporation, Lakewood, NJ, USA) and 0.05% trypsin/0.53 mM 
EDTA (Gibco, Invitrogen Corporation, Basel, Switzerland), stained with trypan blue 0.4% 
(Sigma-Aldrich, Fluka Chemie AG, Buchs, Switzerland), counted and re-plated at a density of 3 
x 103 per cm2. When reaching again subconfluency, BMSC were detached and used for all the 
experimental conditions described below. 
 
Clonogenicity and differentiation assays 
Fibroblastic colony forming unit (CFU-f) assays were performed for each aspirate to determine 
the fraction of clonogenic BMSC. Briefly, 1 x 105 nucleated cells were plated in duplicate in 28 
cm2 tissue culture dishes, and cultured as described above for a total of 14 days, such that 
colonies were clearly visible but not yet overlapping. Colonies were then rinsed with PBS, fixed 
with 4% buffered formaldehyde, stained with 1% methylene blue (Fluka Chemie GmbH, 
Buchs, Switzerland) and counted. Mean values of CFU-f frequency were used to derive the 
initial number of BMSC from each bone marrow sample, which was required to calculate the 
fold expansion and doubling time during the first passage. 
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 Osteogenic differentiation assays were performed by plating in duplicate 3 x 103 expanded 
BMSC per cm2 in complete medium, without (as control) or with further addition of 10 nM 
dexamethasone, 0.1 mM L-ascorbic acid-2-phosphate (Sigma-Aldrich, Fluka Chemie AG, 
Buchs, Switzerland) and 10 mM β-glycerolphosphate (Sigma-Aldrich, Fluka Chemie AG, 
Buchs, Switzerland) (osteogenic medium). After 3 weeks of culture, extracellular matrix 
mineralization and calcium nodule formation were assessed by staining with a 2% alizarin red 
solution (Sigma-Aldrich, Fluka Chemie AG, Buchs, Switzerland). 
 
Ceramic scaffolds 
Porous ceramic scaffolds (porosity: 80 ± 3%, pore size distribution: 22%, < 100 µm; 32%, 
100-200 µm; 40%, 200-500 µm; 6%, > 500 µm) made of 100% hydroxyapatite, with a Ca/P 
ratio of 1.66 ± 0.5 (Engipore®, Fin-Ceramica, Faenza, Italy, http://www.fin-
ceramicafaenza.com), were fabricated in the shape of large tapered cylinders (30 mm height, 
20 mm upper base diameter, 10 mm lower base diameter, 5.5 cm3 volume) or small disks (4 
mm height, 8 mm diameter, 0.2 cm3 volume) (Fig. 1). Scaffolds in the shape of tapered 
cylinders were employed to assess tissue ingrowth and new bone formation at different 
diameters, while disks were used to validate the in vivo osteogenic capacity of rabbit BMSC. 
 
Three-dimensional (3D) perfusion seeding 
Expanded BMSC were seeded in disks or tapered cylinders using a previously described 
bioreactor system [26], based on the principle of direct perfusion of a single cell suspension 
through the interconnected pores of 3D scaffolds. Briefly, scaffolds were pre-wetted in 
complete medium and press-fitted into custom-made polycarbonate chambers (one scaffold 
per chamber), positioned at the bottom of two vertical Teflon-columns and connected with 
each other at their base through a U-shaped tubing. BMSC suspended in 10 ml of complete 
medium were introduced into the bioreactor and perfused through the ceramic pores in 
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 alternating directions at a flow rate of 1.2 ml/minute for 18 hours using a standard syringe 
pump (Programmable PHD 2000®, Harvard Apparatus, Holliston, MA, USA). A seeding 
density of 10 x 106 cells per cm3 of ceramic was consistently used, corresponding to a total 
number of 55 x 106 BMSC for tapered cylinders and 2 x 106 BMSC for disks. All 3D 
perfusion cultures were incubated in humidified atmosphere at 37ºC / 5% CO2. 
The uniformity of 3D perfusion seeding of rabbit BMSC in tapered cylinders was tested in 4 
independent experiments. Following 18 hours of perfusion as described above, cell-scaffold 
constructs were retrieved from the bioreactor, bisected longitudinally and cut into 3 cross-
sections of 10 mm thickness. The uniformity of cell distribution within cross-sections was 
qualitatively assessed by staining with MTT (Sigma-Aldrich, Fluka Chemie AG, Buchs, 
Switzerland).  
 
Construct implantation 
Cell-seeded ceramic scaffolds were retrieved from the bioreactor, rinsed in PBS, placed in 
sterile Falcon tubes pre-filled with PBS, and transferred to the operating room. After the 
surgical site on the dorsum of animals was shaved, disinfected, and draped, a midline skin 
incision was made to expose the panniculus carnosus. An anteriorly pedicled 6.5 cm wide and 8 
cm long panniculus carnosus flap centered over its axial vascular pedicle was raised on one 
side, whereas a submuscular pocket was created on the other side. Then, two large autologous 
cell-scaffold constructs were implanted on opposite sides: one was first wrapped in a panniculus 
carnosus flap and the flap then covered by a semipermeable membrane (group 1, vascularized 
condition, Fig. 2a), whereas the other one was first covered by a semipermeable membrane and 
then placed under the panniculus carnosus as a control (group 2, non-vascularized condition, 
Fig. 2b). Instead of silicone sheeting, which has previously been used to prevent vascular 
invasion of prefabricated flaps from surrounding tissues [25], a semipermeable membrane 
(Biobrane®, UDL Laboratories Inc., Rockford, IL, USA) was employed in the present study. 
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 The material is permeable to oxygen and nutrients, and allows drainage of exudate through 
small pores, thereby preventing the accumulation of wound fluid and seroma formation. The 
membrane, which is usually applied on the skin as a temporary substitute, consisted of a 
silicone surface, which was applied in contact with the cell-scaffold construct, and a nylon-
collagen surface, facing the surrounding soft tissues. The membrane edges were meticulously 
sutured with non-resorbable synthetic monofilament materials (Prolene® 4.0, Ethicon Inc., 
Norderstedt, Germany) to prevent construct invasion by surrounding tissues. The control group 
(group 2) was aimed at testing potential adverse reactions of Biobrane® (e.g., immunological 
response to the collagen surface), as well as to establish the baseline tissue formation, in the 
presence of oxygen and nutrient diffusion but in the absence of vascular invasion. In addition, 
two small disk-shaped scaffolds were implanted subcutaneously at opposite ends of the skin 
incision in the same animal (Fig. 2c): one was uniformly seeded in the perfusion system with 
autologous BMSC to determine their ectopic osteogenic capacity (group 3), while the other one 
was maintained cell-free, as a control to investigate spontaneous tissue formation within the 
ceramic material (group 4). 
 
Construct explantation 
Rabbits were euthanized by intravenous injection of pentobarbital (Nembutal®, Sanofi, Basel, 
Switzerland) after 8 or 12 weeks of implantation (n= 6 animals per time point, randomly 
assigned), and constructs retrieved. Engineered bone flaps (group 1) were harvested together 
with the surrounding semipermeable membrane; the vascular pedicle was always isolated at the 
flap base and inspected for patency. After division of the vascular pedicle, the membrane and 
the flap were removed, the construct was exposed and assessed macroscopically for signs of 
infection and external vascularization. Non-vascularized constructs (group 2) were also 
harvested together with the membrane and assessed macroscopically for signs of local wound 
reaction, infection and vascular penetration through the membrane pores with untoward 
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 vascularization of the constructs. Samples were then assessed for magnetic resonance imaging 
and micro-computerized tomography, and finally processed for histological analyses. 
 
Histology 
All explanted constructs were bisected along the vertical axis; one half was fixed in 4% 
formalin supplemented with 1% calcium chloride and embedded in polymethylmethacrylate, 
while the second was fixed in 4% buffered formaldehyde, decalcified (Osteodec®, Bio-Optica, 
Milan, Italy) and embedded in paraffin. For tapered cylinders, the two halves were 
histologically assessed at 3 different levels, by cross-sectioning at the levels of 18mm (level A), 
15mm (level B) and 12mm (level C) of cylinder diameter. Undecalcified samples were 
histologically assessed by 170 ± 3 µm-thick sections stained with McNeal tetrachrome, in order 
to quantify the extent of connective and bone tissue ingrowth as described below, while 
decalcified specimens were assessed by 5 μm-thick sections stained with hematoxylin/eosin, in 
order to quantify the amount and uniformity of bone tissue formation, as described below.  
 
Quantitative histomorphometry 
Connective and bone tissue ingrowth was assessed by computer-assisted analysis of digitized 
microscopical images of McNeal tetrachrome stained sections. Tissue ingrowth was measured 
using a digital calliper as the distance from the outer border of the scaffold to the inner limit 
of tissue formation perpendicular to the circumference of the scaffold. For each disk and for 
each diameter in tapered cylinders, 3 sections were analysed and 3 measurements per section 
were performed. 
The amount and uniformity of bone formation were assessed by computer-assisted 
histomorphometry of microscopical images acquired both in transmitted and fluorescent light 
(excitation wavelength 546 nm, emission wavelength 590 nm) from hematoxylin/eosin 
stained sections, as previously described [28]. Briefly, the amount of bone tissue was 
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 quantified in each image as the area of fluorescent tissue, and the area available for tissue 
ingrowth (i.e., pore space) was determined by subtracting the area of undegraded scaffold, 
quantified in the transmitted light images, from the total cross-sectional area. For each image, 
the amount of bone tissue was then calculated as a percentage of the total available pore 
space. For each disk and for each diameter in tapered cylinders, a total of 9 sections were 
analysed by acquisition of 6 images per section, in order to cover most of the total cross-
sectional area. The amount of bone formation was calculated as the average and standard 
deviation of the percentages measured in the 9 sections. 
 
Magnetic resonance imaging (MRI) 
High resolution MRI was performed on a 3.0 Tesla head scanner (Magnetom AllegraTM, 
Siemens Medical Solutions, Erlangen, Germany) using the standard head coil for signal 
excitation and reception. A three-dimensional turbo-spinecho sequence with the following 
parameters was used for imaging: 2000 ms repetition time (TR), 15 ms echo time (TE), 384 x 
144 x 86 matrix size, 154 x 77 x 58 mm3 field-of-view (FOV), 5 turbo-factor. To increase the 
signal-to-noise ratio, 8 signal averages were acquired, resulting in a total measurement time of 
approximately 12 hours. To optimize the T1 contrast between ingrowing tissue and porous 
ceramic, an inversion recovery magnetization preparation with an inversion time (TI) of 400 ms 
was applied. Images were Fourier-interpolated to a voxel size of 0.4 x 0.5 x 0.4 mm3. In all 
vascularized constructs (group 1), the region filled with connective tissue was distinguished 
from the empty pores by a segmentation procedure, thus allowing to quantify the distance of 
tissue ingrowth from the construct edges. The accuracy of MRI in detecting connective tissue 
ingrowth was validated by comparing measurements with those derived from analysis of 
histological sections in corresponding regions (i.e., at level B).  
 
Micro-computed tomography (μCT) 
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 A high speed μCT scanner for in vivo applications (vivaCT 40TM, Scanco Medical AG, 
Bassersdorf, Switzerland) with a maximum scan diameter of 20-38 mm and a maximum scan 
length of 145 mm at a nominal isotropic resolution of 10-72 μm was used. As volume of 
interest (VOI), cross-sections of 1.5 mm thickness at 15 mm diameter of vascularized (group 
1) and non-vascularized (group 2) tapered cylinders, corresponding to the level B of 
histological specimens, were scanned at a resolution of 20 μm. 2D images acquired by the 
system from a total of 88 slices in the VOI were used to reconstruct 3D images of the outer 2 
mm of tapered cylinders, previously determined by histology as the area where bone tissue 
formation was limited. While a clear distinction between ceramic and newly formed bone 
could not be established based on the scans, the technique was used to quantify the combined 
amount of ceramic plus newly formed bone in each construct, excluding the remaining soft 
tissues. The threshold employed for the segmentation was set at 325 mg/cm3 based on an 
initial validation of the method, using ceramic specimens where the depth of bone formation 
was histologically established. 
 
Statistics 
Statistical calculations were performed using the SPSS 15.0 statistical software package (SPSS 
Schweiz AG, Zürich, Schweiz). All data from the in vitro studies on cell characterization and 
seeding efficiency/uniformity are presented as mean ± standard deviation of values determined 
for each bone marrow aspirate and each construct. Differences between groups were assessed 
using Mann-Whitney U-tests and, unless otherwise specified, were considered statistically 
significant with p < 0.05.  
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 RESULTS 
BMSC cultures 
The total number of nucleated cells harvested from processed bone marrow aspirates averaged 
124.8 x 106 ± 20.3 x 106 (7.8 x 106 ± 2.4 x 106 cells per ml of aspirate), of which 0.018 ± 0.012 
% were fibroblastic clonogenic cells (CFU-f). The average proliferation rate of BMSC was 0.78 
± 0.13 doublings per day during the first passage and 0.68 ± 0.01 doublings per day during the 
second passage. The CFU-f percent and proliferation rate of rabbit BMSC were comparable to 
those previously reported for other mammalian species, including human [29] and sheep [30]. 
Deposition of mineralized extracellular matrix, in the form of nodules positively stained by 
alizarin red, was evident using cells of 8 out of 12 animals following culture with osteogenic 
medium, and not detectable following culture with control medium. 
Preliminary experiments on perfusion seeding of the tapered cylinders indicated a uniform 
spatial distribution of seeded cells within cross-sections at different diameters, as qualitatively 
assessed by MTT stain (data not shown). 
 
Explant analyses 
Macroscopically, all implants were intact and could be further processed as planned, with the 
exception of one (from group 2) which was infected and was thus excluded from the study. 
Tapered cylinders implanted under vascularized conditions (group 1) could be dissected from 
surrounding tissues and maintained an intact vascular pedicle (Fig. 3). 
Histological assessment indicated absence of vasculature or soft tissue ingrowth into the tapered 
cylinders in the presence of the semipermeable membrane (group 2). Instead, vascularized 
connective tissue was found throughout the entire available pore spaces in disks (groups 3 and 
4) and in the outer pore spaces in tapered cylinders from group 1, leaving a central necrotic core 
with empty pores (Fig. 4). In constructs from group 1, the depth of connective tissue ingrowth 
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 was consistent in cross-sections at different diameters and was significantly higher after 12 
weeks (3.7 ± 0.6 mm) as compared to 8 weeks of implantation (3.1 ± 0.7 mm) (Fig. 5a). 
Bone tissue was not detected under non-vascularized conditions (group 2) or in cell-free disks 
(group 4), whereas it was formed in 9 out of 12 animals within autologous cell-based constructs 
implanted under vascularized conditions (groups 1 and 3). Interestingly, except for one case, we 
observed a direct correspondence between the capacity of cells from different animals to form 
bone tissue in vivo and to deposit mineralized matrix in vitro. In cell-loaded disks (group 3) 
newly formed bone tissue was distributed irregularly, though predominantly in the outer pores, 
whereas in tapered cylinders (group 1) it was clearly confined within an outer region (Fig. 4). 
The depth of bone tissue formation in constructs from group 1 was consistent in cross-sections 
at different diameters and was significantly higher after 12 weeks (maximum depth: 1.8 mm; 
average: 1.4 ± 0.6 mm) as compared to 8 weeks of implantation (maximum depth: 1.3 mm; 
average: 1.0 ± 0.4 mm) (Fig. 5b). Bone matrix filled an average of 6.6 ± 9.8% and 9.1 ± 7.6% of 
available pore space respectively in disks (group 3) and in the outer 2 mm of tapered cylinders 
(group 1), with comparable amounts in cross-sections at different diameters (Fig. 6).  
Magnetic resonance imaging of explanted cylinders indicated clear spatial differences in the T1 
signal of constructs under vascularized conditions (group 1), allowing to distinguish between an 
outer and an inner zone (Fig. 7). The depth of the outer zone, quantified at a 15-mm diameter 
cross-section of the cylinders (level B), was significantly higher after 12 weeks (4.0 ± 0.6 mm) 
as compared to 8 weeks of implantation (3.5 ± 0.7 mm), and corresponded to the histologically 
assessed region filled with connective tissue. The signal intensity measured in the inner zone 
was similar to that measured throughout cylinders under non-vascularized conditions (group 2), 
and thus corresponded to the absence of tissue in the necrotic core (data not shown). 
Micro-computerized tomography scans of explanted cylinders allowed to distinguish between 
the connective tissue and the combination of bone tissue and ceramic scaffold, based on a 
density threshold. As compared to control cylinders under non-vascularized conditions (group 
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 2), deposition of new bone in the pores of tapered cylinders implanted under vascularized 
conditions (group 1) was characterized by changes in all morphometric parameters (Fig. 8 and 
Table I). In particular, constructs from group 1 had a significantly higher trabecular number 
(1.31-fold), trabecular volume (1.25-fold), and trabecular thickness (1.09-fold), lower 
trabecular separation (1.43-fold), higher connectivity density (i.e., the number of trabecular 
connections in a given volume; 1.57-fold), higher structure model index (i.e., ratio of convex 
to concave structures; 2.03-fold), and higher density of the mineralized phase (1.26-fold). 
Differences between group 1 and group 2 in all trabecular characteristics, with the exception 
of the trabecular thickness, were more marked after 12 weeks as compared to 8 weeks of 
implantation, although these trends were not statistically significant. 
 
DISCUSSION 
In this study, we first established a new rabbit model of ectopic prefabrication of autologous 
BMSC-based engineered bone flaps, in a size which is sufficiently large to detect critical size-
related limits in tissue ingrowth and bone formation. We then used the model to establish that 
bone formation is initially limited to the outer periphery of the constructs and progressively 
proceeds towards the center, preceeded by connective tissue formation and reaching a 
maximum depth of 1.8 mm after 12 weeks. 
The developed model was based on the following main components: (i) the panniculus carnosus 
flap, which was sufficiently extended to entirely cover the large cell-scaffold constructs and 
which included an abundant vascular network supplied by defined axial vessels and a vascular 
pedicle [31]; (ii) the semipermeable membrane, which was wrapped around the prefabricated 
bone flap in order to prevent adherence to the surrounding tissue and thus potentially allow 
orthotopic transfer through the vascular pedicle at a later stage [25]; (iii) the porous ceramic 
material, previously used in conjunction with BMSC of various species to generate osteogenic 
grafts [29,30], and here shaped in the form of tapered cylinders to establish that the process of 
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 bone tissue formation in the scaffold is effectively regulated by the distance from the flap; (iv) 
the perfusion bioreactor system, which was instrumental to achieve a uniform loading of the 
cells into the large scaffold, and thus to exclude that the pattern of bone tissue formation was 
possibly related to that of initial cell distribution [26]. 
Histological analyses of connective tissue and bone tissue ingrowth in the construct were 
complemented by non-invasive techniques allowing 3D rendering of the data, namely magnetic 
resonance imaging and micro-computerized tomography scans. We first verified that magnetic 
resonance imaging allowed to distinguish between pores remaining empty and pores filled with 
tissue, based on histological assessments performed in corresponding regions. We then used the 
method to establish that tissue ingrowth from any side of the construct was dependent upon the 
distance from the flap and proceeding towards the center at the rate of about 55 µm per day 
during the first 8 weeks, and of about 21 µm per day between 8 and 12 weeks. The relatively 
lower rate, as compared to that of at least 150 µm per day reported for vascular invasion of 
orthotopical cancellous or cortical bone grafts in rabbits [32], could be due to (i) consequences 
of tissue injury during flap prefabrication, since the flap was used immediately after harvesting, 
with no ischemic preconditioning, and/or (ii) the composition, structure and porosity of the 
different graft materials.  
Micro-computerized tomography scans in the outer 2 mm of vascularized constructs indicated 
significant changes in most of the assessed morphometric parameters as compared to the non-
vascularized grafts containing no bone tissue. This finding confirms that micro-computerized 
tomography parameters, previously shown to correlate with histomorphometrical bone 
measurements [33,34], may also be used to characterize newly formed bone tissue within 
porous scaffolds. The fact that the technique was not able to distinguish between the ceramic 
scaffold and newly formed bone tissue highlights that more sophisticated approaches (e.g., 
those based on synchrotron radiation) are necessary to replace conventional histomorphometry 
in bone tissue engineering [35]. 
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 Histological analysis of tissue formation within cross-sections of the prefabricated flap 
indicated three distinct zones: an outer one, including newly formed bone tissue; a middle zone, 
formed by a fibrous connective tissue; and a central zone, containing only remnants of cells and 
essentially necrotic. Between 8 and 12 weeks, the region containing bone tissue extended 
towards the center of about 0.5 mm, corresponding to a rate of about 18 µm per day. The rate is 
relatively lower as compared to that recently reported for engineered bone tissue in goats (about 
100 µm per day), probably due to the fact that in that study the implantation was orthotopic and 
the ceramic scaffolds intrinsically osteoinductive [36]. In our model, the use of unlabelled 
autologous cells did not allow to determine whether survival of the implanted cells was limited 
to a specific region, nor whether bone formation between 8 and 12 weeks was based on 
osteoconduction from the initially formed bone or on activation of implanted cells which 
remained latent in the first period after implantation. However, the clear centripetal temporal 
progression found indicates that the process of bone formation was not relying on the diffusion 
of nutrients from the construct edge, which would be expected to remain similar over time or 
decrease as new matrix is formed, but rather on the progressive vascularization of the graft.  
The findings of the present study thus prompt for the implementation of strategies to improve 
construct vascularization, in order to possibly accelerate bone formation towards the core of the 
grafts. In this context, several promising approaches have been outlined, although to our 
knowledge not yet successfully validated in the context of bone tissue engineering.  One of 
these options is based on cell seeding of a construct supplied by an arteriovenous loop only a 
few days after its generation, during the period of intense angiogenesis [37]. Alternatively, 
specific factors supporting recruitment and stabilization of blood vessels, including VEGF and 
PDGF, could be delivered from the construct, possibly using vehicles allowing defined release 
kinetics [38] or genetic cell modifications avoiding aberrant hemangiomas [39]. Yet another 
strategy would be based on the co-seeding of endothelial cells, which would form a network 
capable to rapidly connect with the host vasculature in a process called ‘inosculation’ [40]. 
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 Towards the latter possibility, the use of adipose tissue-derived cells would allow the isolation 
of both osteoblastic- and endothelial-lineage cells from the same source, and thus the 
engineering of both osteogenic and vasculogenic grafts [41].  
 
CONCLUSIONS 
In this study, we developed a model of ectopic prefabrication of large engineered bone flaps in 
rabbits, by combining the concepts of cell-based bone tissue engineering and of flap 
prefabrication. Analysis of bone formation demonstrated the viability of the developed concept 
and established size-related limits in bone flap prefabrication in the model. In parallel to the 
implementation of strategies to improve construct vascularization, it will now be important to 
assess whether orthotopic transfer of the ectopically prefabricated engineered bone flap would 
lead to a superior efficacy in the treatment of critically sized bone defects, as compared to direct 
orthotopic implantation of the grafts.  
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 Table I. Micro-computerized tomography parameters1 
 Group 1 Group 2 
 Vascularized Condition Non-Vascularized Condition 
Trabecular Number (n) 6.98 ± 0.85** 5.32 ± 0.99 
Trabecular Volume (%) 42.27 ± 4.11** 33.84 ± 4.03 
Trabecular Thickness (mm) 0.14 ± 0.01** 0.13 ± 0.01 
Trabecular Separation (mm) 0.16 ± 0.03** 0.23 ± 0.05 
Connectivity Density (1/mm3) 124.61 ± 37.17** 79.36 ± 36.00 
Structure Model Index2 1.54 ± 0.52** 0.76 ± 0.015 
Material Density (mg/cm3) 595.10 ± 41.15** 472.79 ± 44.36 
 
1 The typical histomorphometric parameter is here referring to the combined amount of ceramic plus newly formed bone.  
2 The index reflects the ratio of convex to concave structures and is increased if bone tissue is deposited on the concave ceramic pore surfaces.  
** Statistically significant difference between vascularized and non-vascularized conditions (p < 0.01). 
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 FIGURE LEGENDS 
 
Figure 1  
Porous ceramic scaffolds made of 100% hydroxyapatite (Engipore®) were fabricated in the 
shape of large tapered cylinders (30 mm height, 20 mm upper base diameter, 10 mm lower base 
diameter, 5.5 cm3 volume) or small disks (4 mm height, 8 mm diameter, 0.2 cm3 volume). 
 
Figure 2 
(A) In group 1, a large autologous cell-seeded tapered cylinder was first wrapped in a 
panniculus carnosus flap and then covered by a semipermeable (Biobrane®) membrane. The 
flap wrapped around the cell-scaffold construct is depicted prior to its coverage with a sheet of 
Biobrane®, which is positioned under the flap (asterix). (B) In group 2, a large autologous cell-
seeded tapered cylinder was first covered by a semipermeable membrane and then placed under 
the panniculus carnosus as a control. The cell-scaffold construct wrapped with Biobrane® is 
shown in situ under the panniculus carnosus. (C) In groups 3 and 4, two small disks were 
implanted subcutaneously, of which one was uniformly seeded with autologous BMSC and the 
other maintained cell-free. The cell-scaffold construct (left side, long arrow) and the empty 
scaffold (right side, short arrow) are shown in situ at opposite ends of the skin incision. 
 
Figure 3 
(A) In group 1, the intact vascular pedicle (arrow) is demonstrated after dissection of the 
prefabricated flap from the surrounding tissues. (B) After removal of the flap, invasion of the 
outer pores by the flap tissue is visible macroscopically over the entire construct surface. (C) In 
group 2, the outer nylon-collagen surface of Biobrane® shows vascular invasion (arrow) from 
the surrounding tissues. (D) However, after removal of the membrane, no tissue or vessels have 
penetrated the membrane and grown into the construct pores. 
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Figure 4  
Representative histological sections of explanted tapered cylinders from group 1 stained with 
McNeal tetrachrome after 8 or 12 weeks of implantation. Constructs displayed three distinct 
zones: an outer one, including newly formed bone tissue (b, red stain); a middle zone, formed 
by a fibrous connective tissue (c, blue stain); and a central zone, containing only empty pores 
(*). The undegraded scaffold (s) is stained brown. 
 
Figure 5  
In explanted tapered cylinders from group 1, the depth of connective tissue (A) and bone tissue 
(B) ingrowth, as assessed by histology, was consistent in cross-sections at different diameters 
and significantly higher after 12 weeks as compared to 8 weeks of implantation (* = p < 0.05).  
 
Figure 6  
In explanted tapered cylinders from group 1, the amount of bone tissue, as assessed by 
quantitative histomorphology of the outer 2 mm of histological cross-sections, was similar at 
different diameters. 
 
Figure 7  
Magnetic resonance images of explanted tapered cylinders from group 1 demonstrate spatial 
differences in the T1 signal, allowing to distinguish between an outer (dark grey) zone, 
corresponding to the region filled with connective tissue, and an inner (light grey) zone, where 
pores were essentially empty. At 15 mm diameter of tapered cylinders, the depth of the outer 
zone was higher after 12 weeks as compared to 8 weeks of implantation. 
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 Figure 8  
Micro-computerized tomography scans of the outer 2 mm of explanted tapered cylinders 
implanted under vascularized (group 1) or non-vascularized conditions (group 2). Images were 
segmented at a density threshold at 325 mg/cm3, allowing to distinguish the combination of 
bone tissue and ceramic scaffold (filled volume) from the connective tissue (void volume). 
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